During the past decade, Cer San Juan, Centro Polivalente de Asistencia e Investigacion Clinica conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 18 clinical trials were completed, i.e. on average, 69.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 15 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cer San Juan, Centro Polivalente de Asistencia e Investigacion Clinica" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "EMD Serono Research & Development Institute, Inc." with 4 trials sponsored, "Genentech, Inc." with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "R-Pharm International, LLC" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cer San Juan, Centro Polivalente de Asistencia e Investigacion Clinica" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Cer San Juan, Centro Polivalente de Asistencia e Investigacion Clinica" are "Rheumatoid Arthritis" (9 trials), "Lupus Erythematosus, Systemic" (5 trials), "Systemic Lupus Erythematosus" (4 trials), "Lupus Nephritis" (2 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Cer San Juan, Centro Polivalente de Asistencia e Investigacion Clinica" in a lesser frequency.

Most popular intervention types in "Cer San Juan, Centro Polivalente de Asistencia e Investigacion Clinica" are "Drug" (29 trials), "Biological" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "GDC-0853" (4 trials), "Abemaciclib" (3 trials), "Carboplatin" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Cer San Juan, Centro Polivalente de Asistencia e Investigacion Clinica" are 28 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cer San Juan, Centro Polivalente de Asistencia e Investigacion Clinica". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Cer San Juan, Centro Polivalente de Asistencia e Investigacion Clinica, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Cer San Juan, Centro Polivalente de Asistencia e Investigacion Clinica, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".